The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome
Open accessAbstract
Mutations in the human telomerase RNA (TERC) occur in autosomal dominant dyskeratosis congenita (DKC). Because of the possibility that TERC mutations might underlie seemingly acquired forms of bone marrow failure, we examined blood samples from a large number of patients with aplastic anemia (AA), paroxysmal nocturnal hemoglobinuria (PNH), and myelodysplasia (MDS). Only 3 of 210 cases showed heterozygous TERC mutations: both nucleotide 305 (n305) (G>A) and n322 (G>A) were within the conserved region (CR) 4–CR5 domain; n450 (G>A) was localized to the boxH/ACA domain. However, only one patient (with a mutation at n305 [G>A]) had clinical characteristics suggesting DKC; her blood cells contained short telomeres and her sister also suffered from bone marrow failure. Another 21 patients with short telomeres did not show TERC mutations. Our results suggest that cryptic DKC, at least secondary to mutations in the TERC gene, is an improbable diagnosis in patients with otherwise typical AA, PNH, and MDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Around 9% of patients with acquired aplastic anaemia carry mutations in the telomerase components TERC, TERT and DKC1, which are also mutated in inherited aplastic anaemia, as in dyskeratosis congenita74,75.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [74]
Experimental — accuracy not yet measuredIn the citing paper
“In addition, 3–5% of aplastic anaemia patients carry mutant TERT and TR genes41,72,73.”
From The telomere syndromes (2012) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,862
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Variation is the spice of life
Kruglyak, L., & Nickerson, D. A. (2001) · Nature Genetics · doi:10.1038/85776 · Cited by 927
Human Telomerase and Its Regulation
Cong, Y.-S., Wright, W. E., & Shay, J. W. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.3.407-425.2002 · Cited by 898
Hematology of Infancy and Childhood.
(1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-587_2 · Cited by 893
Secondary Structure of Vertebrate Telomerase RNA
Chen, J.-L., Blasco, M. A., & Greider, C. W. (2000) · Cell · doi:10.1016/s0092-8674(00)80687-x · Cited by 605
Dyskeratosis congenita in all its forms
Dokal, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02109.x · Cited by 575
Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry
Rufer, N., Dragowska, W. H., Thornbury, G., Roosnek, E. E., & Lansdorp, P. M. (1998) · Nature Biotechnology · doi:10.1038/nbt0898-743 · Cited by 551
Self-citation
Research works printed but not linked: 1
- Kawar NM, Ivanovich J, Rothbaum RJ, et al. Human telomerase RNA mutation in patients with bone marrow failure [abstract]. Blood. 2002;100: 232a.
Cited by
Sorted by citations
Items 101–200 of 300
The emerging role of pseudogene expressed non-coding RNAs in cellular functions
Groen, J., Capraro, D., & Morris, K. V. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.008 · Cited by 69
Li, Q., Du, J., Feng, R., Xu, Y., Wang, H., Sang, Q., Xing, Q., Zhao, X., Li, J., He, L., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3685 · Cited by 66
Marrone, A., Sokhal, P., Walne, A. J., Beswick, R. W., Kirwan, M., Killick, S. B., Williams, M., Marsh, J. C. W., Vulliamy, T., & Dokal, I. S. (2007) · Haematologica · doi:10.3324/haematol.11407 · Cited by 69
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of TelomeresPreprint
Roake, C. M., & Artandi, S. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026088 · Cited by 70
Recent advances in understanding clonal haematopoiesis in aplastic anaemia
Stanley, N. L., Olson, T. S., & Babushok, D. V. (2017) · British Journal of Haematology · doi:10.1111/bjh.14510 · Cited by 65
Triallelic and epigenetic-like inheritance in human disorders of telomerase
Collopy, L. C., Walne, A. J., Cardoso, S. R., de la Fuente, J., Mohamed, M., Toriello, H. V., Tamary, H., Ling, A. J. Y. V., Lloyd, T., Kassam, R., et al. (2015) · Blood · doi:10.1182/blood-2015-03-633388 · Cited by 66
The role of telomeres and telomerase in the pathology of human cancer and aging
Shin, J., Hong, A., Solomon, M. J., & Lee, C. S. (2006) · Pathology · doi:10.1080/00313020600580468 · Cited by 66
The Spectrum of Hepatic Involvement in Patients With Telomere Disease
Kapuria, D., Yakov, G. B., Ortolano, R., Cho, M. H., Kalchiem‐Dekel, O., Takyar, V. K., Lingala, S., Gara, N., Tana, M. M.-S., Kim, Y. J., et al. (2019) · Hepatology · doi:10.1002/hep.30578 · Cited by 68
Self-citationRecognizing familial myeloid leukemia in adults
Nickels, E. M., Soodalter, J. A., Churpek, J. E., & Godley, L. A. (2013) · Therapeutic Advances in Hematology · doi:10.1177/2040620713487399 · Cited by 68
Tiu, R. V., Gondek, L. P., O'Keefe, C., & Maciejewski, J. P. (2007) · Leukemia · doi:10.1038/sj.leu.2404757 · Cited by 60
Telomere dysfunction and its role in haematological cancer
Jones, C. H., Pepper, C. J., & Baird, D. M. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09022.x · Cited by 60
Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms
Marsh, J. C. W., Gutierrez‐Rodrigues, F., Cooper, J., Jiang, J., Gandhi, S., Kajigaya, S., Feng, X., Ibanez, M. D. P. F., Donaires, F. S., da Silva, J. P. L., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017008110 · Cited by 58
Self-citationDyskeratosis congenita and telomerase
Bessler, M., Wilson, D. B., & Mason, P. J. (2004) · Current Opinion in Pediatrics · doi:10.1097/00008480-200402000-00006 · Cited by 59
Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells
Drummond, M. W., Balabanov, S., Holyoake, T. L., & Brümmendorf, T. H. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0057 · Cited by 60
Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Knipp, S., Hildebrandt, B., Richter, J., Haas, R., Germing, U., & Gattermann, N. (2005) · PubMed · Cited by 57
Advances in quantum dot-based biosensors for DNA-modifying enzymes assay
Zhang, Q., Zhang, X., Ma, F., & Zhang, C. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214674 · Cited by 55
Diagnosis of acquired aplastic anemia
Rovó, A., Tichelli, A., Dufour, C., & EBMT, O. B. O. T. S.-W. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.230 · Cited by 54
Telomere length in myelodysplastic syndromes
Rollison, D. E. M., Epling‐Burnette, P. K., Park, J. Y., Lee, J., Park, H. K., Jonathan, K. A., Cole, A. L., Painter, J. S., Guerrier, M., MelÉndez-Santiago, J., et al. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.568648 · Cited by 54
Immunologic Aspects of Hypoplastic Myelodysplastic Syndrome
Calado, R. T. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.04.006 · Cited by 52
Feurstein, S. K., Adegunsoye, A., Mojsilovic, D., Vij, R., DePersia, A., Rajagopal, P. S., Osman, A. E. G., Collins, R. H., Kim, R. H., Gore, S. D., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001721 · Cited by 53
Borie, R., Kannengiesser, C., Nathan, N., Tabèze, L., Pradère, P., & Crestani, B. (2014) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2014.07.017 · Cited by 54
Savage, S. A., Stewart, B., Eckert, A. W., Kiley, M., Liao, J. S., & Chanock, S. J. (2005) · Human Mutation · doi:10.1002/humu.20226 · Cited by 52
Self-citationDyskeratosis Congenita: A Disorder of Defective Telomere Maintenance?
Walne, A. J., Marrone, A., & Dokal, I. S. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05067 · Cited by 51
Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita
Agarwal, S. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.04.003 · Cited by 51
Sakaguchi, H., Nishio, N., Hama, A., Kawashima, N., Wang, X., Narita, A., Doisaki, S., Xu, Y., Muramatsu, H., Yoshida, N., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.091165 · Cited by 47
Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia
Savage, S. A., Calado, R. T., Xin, Z.-T., Ly, H., Young, N. S., & Chanock, S. J. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.02.008 · Cited by 47
Self-citationMolecular mechanisms of ageing and related diseases
Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12247 · Cited by 50
Function and Malfunction of Hematopoietic Stem Cells in Primary Bone Marrow Failure Syndromes
Risitano, A. M., Maciejewski, J. P., Selleri, C., Rotoli, B., Risitano, A. M., & Maciejewski, J. P. (2007) · Current Stem Cell Research & Therapy · doi:10.2174/157488807779316982 · Cited by 47
Telomerase RNA processing: Implications for human health and disease
Nagpal, N., & Agarwal, S. (2020) · Stem Cells · doi:10.1002/stem.3270 · Cited by 47
Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.
Liang, J. B., Yagasaki, H., Kamachi, Y., Hama, A., Matsumoto, K., Kato, K., Kudo, K., & Kojima, S. (2006) · PubMed · Cited by 45
Non-canonical roles of canonical telomere binding proteins in cancers
Akıncılar, S. C., Chan, C. H. T., Ng, Q. F., Fidan, K., & Tergaonkar, V. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03783-0 · Cited by 45
Molecular pathogenesis of acquired aplastic anemia
Boddu, P. C., & Kadia, T. M. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13182 · Cited by 44
Fanconi's anaemia and related bone marrow failure syndromes
Dokal, I. S. (2006) · British Medical Bulletin · doi:10.1093/bmb/ldl007 · Cited by 42
A Common Variant in the Telomerase RNA Component Is Associated with Short Telomere Length
Njajou, O. T., Blackburn, E. H., Pawlikowska, L., Mangino, M., Damcott, C., Kwok, P., Spector, T. D., Newman, A. B., Harris, T. B., Cummings, S. R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013048 · Cited by 41
Hematopoietic stem cells in aplastic anemia
Maciejewski, J. P., & Risitano, A. M. (2003) · Archives of Medical Research · doi:10.1016/j.arcmed.2003.09.009 · Cited by 41
Hills, M., & Lansdorp, P. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04565.x · Cited by 42
Self-citationTERC mutations in children with refractory cytopenia.
Ortmann, C. A., Niemeyer, C. M., Wawer, A., Ebell, W., Baumann, I., & Kratz, C. P. (2006) · PubMed · Cited by 40
Gourronc, F. A., Robertson, M. M., Herrig, A. K., Lansdorp, P. M., Goldman, F. D., & Klingelhutz, A. J. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00916.x · Cited by 39
Self-citationRecent progress in dyskeratosis congenita
Nishio, N., & Kojima, S. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0695-5 · Cited by 40
Telomeres and Telomerase in Stem Cells during Aging and Disease
Ju, Z., & Rudolph, K. L. (2006) · KARGER eBooks · doi:10.1159/000092502 · Cited by 39
Beier, F., Balabanov, S., Buckley, T., Dietz, K., Hartmann, U., Rojewski, M., Kanz, L., Schrezenmeier, H., & Brümmendorf, T. H. (2005) · Blood · doi:10.1182/blood-2004-10-3996 · Cited by 39
Ohyashiki, J. H., Hisatomi, H., Nagao, K., Honda, S., Takaku, T., Zhang, Y., Sashida, G., & Ohyashiki, K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602546 · Cited by 39
Tolios, A., Teupser, D., & Holdt, L. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143889 · Cited by 38
Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review
Boddu, P. C., & Kadia, T. M. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1313700 · Cited by 36
Medical genetics and epigenetics of telomerase
Koziel, J. E., Fox, M. J., Steding, C. E., Sprouse, A. A., & Herbert, B. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01276.x · Cited by 37
High incidence of rapid telomere loss in telomerase-deficient Caenorhabditis elegans
Cheung, I. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj417 · Cited by 36
Irvine, A. D., & Mellerio, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch15 · Cited by 35
Keith, W. N., Vulliamy, T., Zhao, J., Ar, M. C., Erzık, C., Bilsland, A. E., Ülkü, B., Marrone, A., Mason, P. J., Bessler, M., et al. (2004) · BMC Hematology · doi:10.1186/1471-2326-4-3 · Cited by 35
Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
Hwang, S. M., Kim, S. Y., Kim, J. A., Park, H.-S., Park, S. N., Im, K., Kim, K., Kim, S., & Lee, D. S. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0287-9 · Cited by 38
Telomerase: not just for the elongation of telomeres
Calado, R. T., & Chen, J. (2006) · BioEssays · doi:10.1002/bies.20365 · Cited by 33
Genetic “lnc”-age of noncoding RNAs to human disease
Troy, A., & Sharpless, N. E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci66645 · Cited by 32
Kamio, T., Ito, E., Ohara, A., Kosaka, Y., Tsuchida, M., Yagasaki, H., Mugishima, H., Yabe, H., Morimoto, A., Ohga, S., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.035600 · Cited by 32
Inherited bone marrow failure syndromes in 2012
Sakaguchi, H., Nakanishi, K., & Kojima, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1249-9 · Cited by 32
Updated Guidelines for the Treatment of Acquired Aplastic Anemia in Children
Yoshida, N., & Kojima, S. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0716-8 · Cited by 31
Telomeres and prognosis in patients with chronic lymphocytic leukaemia
Sellmann, L., de Beer, D., Bartels, M., Opalka, B., Nückel, H., Dührsen, U., Dürig, J., Seifert, M., Siemer, D., Küppers, R., et al. (2011) · International Journal of Hematology · doi:10.1007/s12185-010-0750-2 · Cited by 31
Self-citationDyskerin, telomerase and the DNA damage response
Gu, B.-W., Bessler, M., & Mason, P. J. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7265 · Cited by 31
Errington, T. M., Fu, D., Wong, J. M. Y., & Collins, K. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00777-08 · Cited by 31
Telomere dysfunction in human diseases: the long and short of it!
Carroll, K. A., & Ly, H. (2009) · Europe PMC (PubMed Central) · Cited by 30
Acquired Aplastic Anemia in Childhood
Guinan, E. C. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.011 · Cited by 28
Means to the ends: The role of telomeres and telomere processing machinery in metastasis
Robinson, N. J., & Schiemann, W. P. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.005 · Cited by 28
Field, J. J., Mason, P. J., An, P., Kasai, Y., McLellan, M. D., Jaeger, S. R., Barnes, Y. J., King, A. A., Bessler, M., & Wilson, D. B. (2006) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000212952.58597.84 · Cited by 28
Wang, Y., Yesselman, J. D., Zhang, Q., Kang, M., & Feigon, J. F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607411113 · Cited by 28
Telomere length is an independent prognostic marker in MDS but not in de novo AML
Williams, J., Heppel, N. H., Britt‐Compton, B., Grimstead, J. W., Jones, R. E., Tauro, S., Bowen, D., Knapper, S., Groves, M., Hills, R. K., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14666 · Cited by 28
Hoareau‐Aveilla, C., Henry, Y. A. L., & Leblanc, T. M. (2008) · médecine/sciences · doi:10.1051/medsci/2008244390 · Cited by 32
Takeuchi, J. S., Ly, H., Yamaguchi, H., Carroll, K. A., Kosaka, F., Sawaguchi, K., Mitamura, Y., Watanabe, A., Gomi, S., Inokuchi, K., et al. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.08.002 · Cited by 26
Self-citationTelomere biology: from disorders to hematological diseases
Roka, K., Solomou, E. E., & Kattamis, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1167848 · Cited by 30
Genetic and environmental factors influencing human diseases with telomere dysfunction.
Ly, H. (2009) · PubMed · Cited by 25
Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice
Schratz, K. E., & Dezern, A. E. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.10.002 · Cited by 26
Congenital thrombocytopenia in a neonate with an interstitial microdeletion of 3q26.2q26.31
Bouman, A., Knegt, L. C., Gröschel, S., Erpelinck-Verschueren, C. A. J., Sanders, M. A., Delwel, R., Kuijpers, T. W., & Cobben, J. M. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37451 · Cited by 24
Bone Marrow Failure: A Child Is Not Just a Small Adult (But an Adult Can Have a Childhood Disease)
Alter, B. P. (2005) · Hematology · doi:10.1182/asheducation-2005.1.96 · Cited by 25
Sjøgren, T., Bratland, E., Røyrvik, E. C., Grytaas, M. A., Benneche, A., Knappskog, P. M., Kämpe, O., Oftedal, B. E., Husebye, E. S., & Wolff, A. S. B. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102917 · Cited by 24
Ueda, Y., Calado, R. T., Norberg, A., Kajigaya, S., Roos, G., Hellström‐Lindberg, E., & Young, N. S. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-68 · Cited by 24
Self-citationMutations of Telomerase Complex Genes Linked to Bone Marrow Failures
Yamaguchi, H. (2007) · Journal of Nippon Medical School · doi:10.1272/jnms.74.202 · Cited by 22
Self-citationFanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
Przychodzen, B. P., Makishima, H., Sekeres, M. A., Balasubramanian, S. K., Thota, S., Patel, B. J., Clemente, M. J., Hirsch, C. M., Dienes, B., & Maciejewski, J. P. (2017) · Oncotarget · doi:10.18632/oncotarget.23328 · Cited by 23
Human short-term repopulating cells have enhanced telomerase reverse transcriptase expression
Järås, M., Edqvist, A., Rebetz, J., Salford, L. G., Widegren, B., & Fan, X. (2006) · Blood · doi:10.1182/blood-2005-09-008904 · Cited by 23
Tometten, M., Kirschner, M., Meyer, R., Begemann, M., Halfmeyer, I., Vieri, M., Kricheldorf, K., Maurer, A., Platzbecker, U., Radsak, M. P., et al. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000874 · Cited by 24
Yamaguchi, H., Sakaguchi, H., Yoshida, K., Yabe, M., Yabe, H., Okuno, Y., Muramatsu, H., Takahashi, Y., Yui, S., Shiraishi, Y., et al. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1861-6 · Cited by 22
Self-citationRecent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia
Scheinberg, P. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.03.003 · Cited by 22
Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis
Borie, R., Kannengiesser, C., & Crestani, B. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328356b15c · Cited by 22
Role of Germline Genetic Factors in MPN Pathogenesis
Harutyunyan, A. S., & Královics, R. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.07.005 · Cited by 22
Guo, X., Tang, Y., Zhang, P., Li, S., Chen, Y., Qian, B., Shen, H., & Zhao, N. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1263-4 · Cited by 20
Cantara, S., Capuano, S., Capezzone, M., Benigni, M., Pisu, M., Marchisotta, S., & Pacini, F. (2012) · Thyroid · doi:10.1089/thy.2011.0109 · Cited by 19
Calado, R. T., Regal, J. A., Kajigaya, S., & Young, N. S. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02209.x · Cited by 19
Self-citationTsang, H. C., Bussel, J. B., Mathew, S., Liu, Y., Imahiyerobo, A., Orazi, A., & Geyer, J. T. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.218 · Cited by 20
Telomere Dysfunction and Hematologic Disorders
Paiva, R. M. A., & Calado, R. T. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00006-2 · Cited by 18
Wang, Y., McReynolds, L. J., Dagnall, C. L., Katki, H. A., Spellman, S. R., Wang, T., Hicks, B. D., Freedman, N. D., Jones, K. M., Lee, S. J., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16153 · Cited by 18
Telomerase as a clinical target: Current strategies and potential applications
Fleisig, H. B., & Wong, J. M. Y. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.011 · Cited by 18
Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics
Melicher, D., Buzás, E. I., & Falus, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1991-2 · Cited by 17
Introduction to Acquired and Inherited Bone Marrow Failure
Sieff, C. A. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.04.008 · Cited by 17
Impact of germline CTC 1 alterations on telomere length in acquired bone marrow failure
Shen, W., Kerr, C. M., Przychozen, B., Mahfouz, R. Z., LaFramboise, T., Nagata, Y., Hanna, R., Radivoyevitch, T., Nazha, A., Sekeres, M. A., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.15862 · Cited by 17
Folding heterogeneity in the essential human telomerase RNA three-way junction
Palka, C., Forino, N. M., Hentschel, J., Das, R., & Stone, M. D. (2020) · RNA · doi:10.1261/rna.077255.120 · Cited by 18
Ma, F., Wang, T., Jiang, L., & Zhang, C. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.11.058 · Cited by 17
Tang, Y., Chen, J., & Young, N. S. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07509.x · Cited by 16
Self-citationHematopoietic stem cell development, aging and functional failure
Chen, J. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0856-1 · Cited by 16
Vajen, B., Thomay, K., & Schlegelberger, B. (2013) · Cancers · doi:10.3390/cancers5030857 · Cited by 16
Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells
Brzeźniakiewicz‐Janus, K., Rupa‐Matysek, J., & Gil, L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09971-y · Cited by 17
Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia
Pan, P., Chen, C., Hong, J., & Gu, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110036 · Cited by 15
Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility
Wang, X., Li, J., Wu, K., Yang, S., & Chao, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054464 · Cited by 14
Ishii, K., & Young, N. S. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.07.002 · Cited by 13
Self-citationAllogeneic hematopoietic stem cell transplantation for dyskeratosis congenita
Elmahadi, S., Muramatsu, H., & Kojima, S. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000290 · Cited by 13
Metadata
- Authors
- Yamaguchi, H., Baerlocher, G. M., Lansdorp, P. M., Chanock, S. J., Nunez, O., Sloand, E., & Young, N. S.
- Affiliations
- National Institutes of Health (US)
- From the Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; Terry Fox Laboratory, BC Cancer Research Center, Vancouver; Department of Medicine, University of British Columbia, Vancouver, Canada; and the Section on Genomic Variation, Pediatric Oncology Branch, National Cancer Institutes, Advanced Technology Center, Gaithersburg, MD
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2003-08-01
- Volume
- 102
- Issue
- 3
- Pages
- 916-918
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2085418826
- Cited by
- 301
- References
- 27
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 11 · 2022: 5 · 2021: 4 · 2020: 13 · 2019: 9 · 2018: 16 · 2017: 19 · 2016: 12 · 2015: 14 · 2014: 19 · 2013: 13 · 2012: 14
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- telomerase RNA, TERC mutations, aplastic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria, dyskeratosis congenita, bone marrow failure, short telomeres, heterozygous mutation
- MeSH terms
- Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Heterozygote, Humans, Mutation, Myelodysplastic Syndromes, RNA, Case-Control Studies, Telomerase, Dyskeratosis Congenita, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review